期刊文献+

常用甲状腺功能检测指标不同组合模式的临床诊断价值 被引量:7

Diagnosis Value of the Thyroid Gland Function Detection Parameter Common Combination Model
下载PDF
导出
摘要 目的分析比较TSH、T3、FT3、T4及FT4在甲状腺功能紊乱患者体内的变化情况及临床意义。方法应用全自动电化学发光分析仪检测2008年3月~2008年12月3643例门诊、住院患者血清中的TSH、T3、FT3、T4及FT4五种激素水平,按出现结果的方式组合进行统计,并从诊断甲亢和甲低两方面分别统计五种指标的阳性率。结果在诊断甲亢方面,五种指标的阳性率从高到低分别是TSH(27.31%)〉FT3(16.91%)〉FT4(16.55%)〉T3(14.08%)〉T4(7.99%);在诊断甲低方面,五种指标的阳性率从高到低分别是TSH(20.72%)〉FT4(11.61%)〉FT3(10.38%)〉T4(10.29%)〉T3(9.11%)。结论无论是在诊断及指导治疗甲亢还是甲低,TSH都是一项非常灵敏的指标,诊断甲亢时,FT3要优于FT4,在诊断甲低方面,FT4要优于FT3,同时游离类激素比总激素能更好地反映甲状腺功能的实际水平;而五种指标的联合使用,对甲状腺疾病的诊断及治疗用药都有非常重要的指导作用。 Objective To analyze and compare the change of TSH、T3、FT3、T4 and FT4 and the clinical meaning in thyroid function disorder patients.Methods TSH、T3、FT3、T4 and FT4 in 3643 patients'serum samples were detected by automatic electrochemiluminescence analyzer from Mar to Dec in 2008.Results The positive rate of these five index in graves patients aligned from high level to low level were TSH(27.31%)FT3(16.91%)FT4(16.55%)T3(14.08%)T4(7.99%),and in hypothyroidism patients the sequence were TSH(20.72%)FT4(11.61%)FT3(10.38%)T4(10.29%)T3(9.11%).Conclusion No matter in hyperthyroidism or hypothyroidism,TSH was a most sensitive diagnosis parameter.And it was helpful to combine these five parameters in diagnosis and treatment of thyroid disease.
作者 李尔凡 严海燕 钟丽玲 罗晓红 LI Er-fan,YAN Hai-yan,ZHONG Li-ling,LUO Xiao-hong(1.Department of Clinical Laboratory,BoJi-affiliated hospital of Sun Yat-sen University,Guangzhou 511300;2.Department of Clinical Laboratory,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120;3.Department of Clinical Laboratory,Blood Station of Zengcheng City,Guangzhou 511300,China)
出处 《医学信息》 2011年第13期4150-4152,共3页 Journal of Medical Information
关键词 甲状腺功能 检测指标 组合模式 诊断价值 thyroid gland function detection parameter combination model diagnosis value
  • 相关文献

参考文献3

二级参考文献17

  • 1刘东刚,李荣华,葛秀兰,刘文淑,南国珍.200例血清TT_3、TT_4、FT_3、FT_4和TSH测定的临床价值[J].河北医学院学报,1995,16(4):201-203. 被引量:2
  • 2许叔祥.F13、Fr4放免测定的临床应用.核技术,1994,17:5-5. 被引量:1
  • 3Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism [J]. Emdocrinol Metab Clin North Am,2000;29(2):399. 被引量:1
  • 4Smsllridge RC. Disclosing subclinical thyroid disease. An approach to mild laboratory abnormalities and vague or absent symptoms[J]. Postgrad Med, 2000,107(1) : 143. 被引量:1
  • 5Caldwell Y, Hiyama Y, Shimojo N, et al. Autoantibodies to thyroidperoxidase in patientswith chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol, 1985,65 : 534. 被引量:1
  • 6Ridgway EC . Modern concepts of primary thyroid gland failure. Clin Chem,1996,42:179-182. 被引量:1
  • 7Demers LM. Standards of laboratory practice symposium on thyroid-function testing:Introduction. Clin Chem,1996,42:119-120. 被引量:1
  • 8Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA, 1995,273:808-812. 被引量:1
  • 9Spencer CA, Takeuchi M; Kazarosyan M. Current status and performance goals for serum thyrotropin(TSH) assays. Clin Chem, 1996,42:140-145. 被引量:1
  • 10KefferJH. Preanalytical considerations in testing thyroid function. Clin Chem, 1996,42:125-134. 被引量:1

共引文献53

同被引文献30

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部